Stay updated on Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial page.

Latest updates to the Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial page
- Check3 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive content changes.SummaryDifference0.6%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.6%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This suggests a shift towards a more generalized presentation of the study's geographical context.SummaryDifference35%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial page.